Literature DB >> 1271191

Encephalopathy following measles infection in children with chronic illness.

J V Murphy, E J Yunis.   

Abstract

Five patients with an unusual encephalopathy, possible secondary to measles virus infection, are described. Features common to these patients are: an existing chronic disease, neurologic deterioration 2 1/2 to 6 months after a measles infection, and death several weeks later. These events occurred when the chronic disease (e.g. leukemia or neuroblastoma) was in remission. That the measles virus was the causative agent is suggested only by finding in brain and extracranial tissues intracytoplasmic and intranuclear inclusions which contained measleslike particles. Additional clinical features seen in each of the five patients were: seizures, hypertension, and the inappropriate secretion of antidiuretic hormone.

Entities:  

Mesh:

Year:  1976        PMID: 1271191     DOI: 10.1016/s0022-3476(76)81045-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

Authors:  Ben Readhead; Jean-Vianney Haure-Mirande; Cory C Funk; Matthew A Richards; Paul Shannon; Vahram Haroutunian; Mary Sano; Winnie S Liang; Noam D Beckmann; Nathan D Price; Eric M Reiman; Eric E Schadt; Michelle E Ehrlich; Sam Gandy; Joel T Dudley
Journal:  Neuron       Date:  2018-06-21       Impact factor: 17.173

2.  Infantile cortical measles inclusion body encephalitis during combined treatment of acute lymphoblastic leukemia.

Authors:  G Spalke; C Eschenbach
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

3.  Detection of measles virus genome in blood leucocytes of patients with certain autoimmune diseases.

Authors:  O G Andjaparidze; N M Chaplygina; N N Bogomolova; I B Koptyaeva; E G Nevryaeva; R G Filimonova; I E Tareeva
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Neurological complications of childhood leukaemia.

Authors:  R H Campbell; W C Marshall; J M Chessells
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

5.  Measles retinopathy during immunosuppression.

Authors:  M Haltia; A Tarkkanen; A Vaheri; A Paetau; K Kaakinen; H Erkkilä
Journal:  Br J Ophthalmol       Date:  1978-06       Impact factor: 4.638

6.  Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.

Authors:  I Hughes; M E Jenney; R W Newton; D J Morris; P E Klapper
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

7.  Measles virus and subacute neurological disease: an unusual presentation of measles inclusion body encephalitis.

Authors:  D W Chadwick; S Martin; P H Buxton; A H Tomlinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

8.  Role of infection in the death of children with acute lymphoblastic leukaemia.

Authors:  A W Craft; M M Reid; E Bruce; J Kernahan; P S Gardner
Journal:  Arch Dis Child       Date:  1977-10       Impact factor: 3.791

Review 9.  The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.

Authors:  Umar H Iqbal; Emma Zeng; Giulio M Pasinetti
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.